Dr Harold Mitchell Heidt, EDD | |
694 Jamestown Dr, Garden City, SC 29576 | |
(843) 651-4218 | |
(843) 651-1108 |
Full Name | Dr Harold Mitchell Heidt |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 694 Jamestown Dr, Garden City, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689788861 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 00562 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Harold Mitchell Heidt, EDD 694 Jamestown Dr, Garden City, SC 29576 Ph: (843) 651-4218 | Dr Harold Mitchell Heidt, EDD 694 Jamestown Dr, Garden City, SC 29576 Ph: (843) 651-4218 |
News Archive
During the "Novel Implications for Blood Flow and Vascular Dysfunction in Non-cardiovascular Related Disease" symposium at the APS Cardiovascular Aging: New Frontiers and Old Friends conference, researchers will present findings that emphasize the interaction between age-related cardiovascular dysfunction and disease whose risk increases with age.
In a recent quest for an effective antiviral compound, UK researchers have purified a specific enzyme of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) known as nsp15 and optimized fluorescent biochemical endoribonuclease assays to screen a custom chemical library with over 5,000 commercial compounds. The study is currently available on the bioRxiv* preprint server.
GfK Healthcare's Roper Global Diabetes Programme, the definitive global perspective on diabetes, announced today the launch of its enhanced 2009/2010 Western Europe Patient Study. Offering a holistic perspective of the diabetes patient across five European countries, with robust insights into patients' attitudes and behaviors towards treatments, testing and lifestyles, the study now makes available to marketers greater reporting frequency and focus across a variety of broad-based and niche diabetes patient groups.
Researchers in the School of Population Health & Environmental Sciences have found that patients prescribed any of the 12 most commonly used antidepressants were 21% more likely to experience an episode of gain weight than those not taking the drugs, after adjusting for other factors which might affect this result.
Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark, announced today that the U.S. Food and Drug Administration (FDA) has approved ONFI as adjunctive therapy for seizures associated with Lennox-Gastaut syndrome in patients two years and older.
› Verified 8 days ago